Suparma Tbk. vs Reksa Dana Indeks KISI IDX Value30 ETF — how do they compare? Suparma Tbk. trades at Rp166 (market cap 874.19B, 957K 24h volume), while Reksa Dana Indeks KISI IDX Value30 ETF trades at Rp547 (market cap 8.74B, 80.1K 24h volume). The key difference: Suparma Tbk. is far larger — about 100× Reksa Dana Indeks KISI IDX Value30 ETF's market cap, and Suparma Tbk. is more actively traded (957K versus 80.1K). Which is the better fit depends on your goals.
| SPMA | XKIV | |
|---|---|---|
Market Cap | 874.19B | 8.74B |
Volume | 957K | 80.1K |
Lot | 9.57K | 801 |
Turnover | 159.83M | 43.81M |
Average Price | 167.01 | 547 |
Value | 159.83M | 43.81M |
Indicative Equilibrium Price | 166 | — |
Indicative Equilibrium Volume | 50 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Suparma Tbk (Entity) was established under the Domestic Capital Investment Law No. 6 of 1968 as amended by Law No. 12 of 1970 based on the Notarial Deed No. 29 of Tjahjadi Hartanto, S.H., on August 25, 1976. The Entity's name, PT Supar Inpama was changed to PT Suparma based in the Notarial Deed No. 5 dated December 7, 1978 of the same notary.
Read more on SPMA →